Regenerative Bio Inc.

Regenerative Bio is a longevity company driven by artificial intelligence. Founded in 2021 with the vision of "Health Equity - Empowering Everyone to Age Gracefully and Healthily", the company has developed "Organ-level aging clock" technology and applied it into their platform RevOrgan through precise measurements and effective intervertions solutions. Regenerative Bio’s team consisted of world-class scientists and top-level business operation talents. Its Scientific Advisory Board includes renowned professors Dr. George Church, Dr. Vadim Gladyshev and Dr. Tian Xu. The company has raised over $10 million in Angel Round and A Round, backed up by investors including IMO Ventures, 5Y Capital, K2VC, Uphonest Capital, Taihill Venture and Yael Capital.